CIK 0001453593
- Non-accelerated filer
- Smaller reporting company
Xtant Medical Holdings, Inc.
Sign in to watch- Ticker
- XTNT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205313323
- Phone
- +1 406-388-0480
- Business address
- 664 CRUISER LANE, BELGRADE, MT, 59714
- Former names
- Bacterin International Holdings, Inc., K KITZ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-15 | Brandt Kevin D VP & Chief Commercial Officer | Grant or award | +40,000 | 40,000 | ||
| 2018-08-15 | Brandt Kevin D VP & Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +30,770 | 30,770 | ||
| 2018-05-02 | McNamara Robert Director | Grant or award | +20,833 | 20,833 | ||
| 2018-04-09 | BAKEWELL JOHN K Director | Grant or award | +26,042 | 26,042 | ||
| 2018-04-08 | Mainelli Michael Director | Grant or award | +20,833 | 20,833 | ||
| 2018-02-14 | Rizzo Matthew Director | Grant or award | +5,126,534 | $7.20 | $36.9M | 5,287,197 |
| 2018-02-14 | Rizzo Matthew Director | Grant or award | +2,905,396 | $7.20 | $20.9M | 2,973,996 |
| 2018-02-14 | Rizzo Matthew Director | Purchase | +603,687 | $7.20 | $4.3M | 5,890,884 |
| 2018-02-14 | Rizzo Matthew Director | Purchase | +342,132 | $7.20 | $2.5M | 3,316,128 |
| 2018-02-14 | Rizzo Matthew Director | Returned to the company · Convertible Note | −0 | $46.56 | $0 | 0 |
| 2018-02-14 | Rizzo Matthew Director | Returned to the company · Convertible Note | −0 | $46.56 | $0 | 0 |
| 2018-02-14 | Rizzo Matthew Director | Returned to the company · Convertible Note | −0 | $34.80 | $0 | 0 |
| 2018-02-14 | Rizzo Matthew Director | Returned to the company · Convertible Note | −0 | $34.80 | $0 | 0 |
| 2018-02-14 | Eggenberg Michael Director | Grant or award | +5,126,534 | $7.20 | $36.9M | 5,287,197 |
| 2018-02-14 | Eggenberg Michael Director | Grant or award | +2,905,396 | $7.20 | $20.9M | 2,973,996 |
| 2018-02-14 | Eggenberg Michael Director | Purchase | +603,687 | $7.20 | $4.3M | 5,890,884 |
| 2018-02-14 | Eggenberg Michael Director | Purchase | +342,132 | $7.20 | $2.5M | 3,316,128 |
| 2018-02-14 | Eggenberg Michael Director | Returned to the company · Convertible Note | −0 | $46.56 | $0 | 0 |
| 2018-02-14 | Eggenberg Michael Director | Returned to the company · Convertible Note | −0 | $46.56 | $0 | 0 |
| 2018-02-14 | Eggenberg Michael Director | Returned to the company · Convertible Note | −0 | $34.80 | $0 | 0 |
Page 11 of 19 · 371 trades